From: Altered expression of serum lncRNA CASC2 and miRNA-21-5p in COVID-19 patients
 | CASC2 | P-value | MiRNA-21 (log2) | P-value | ||||
---|---|---|---|---|---|---|---|---|
Median | IQR | Median | IQR | |||||
Sex | ||||||||
Female | 0.67 | 0.23 | 0.94 | 0.676 | 8.45 | 5.5 | 10.15 | 0.621 |
Male | 0.7 | 0.37 | 1 | 7.93 | 3.88 | 9.92 | ||
ICU admission | ||||||||
No | 0.85 | 0.58 | 1 | 0.214 | 8.93 | 5.71 | 10.15 | 0.265 |
Yes | 0.57 | 0.26 | 0.9 | 7.93 | 4.58 | 9.19 | ||
DM | ||||||||
No | 0.85 | 0.57 | 1 | 0.303 | 7.93 | 5.06 | 8.84 | 0.551 |
Yes | 0.64 | 0.25 | 0.96 | 8.2 | 4.82 | 10.17 | ||
Hypertension | ||||||||
No | 0.84 | 0.38 | 1.07 | 0.073 | 7.06 | 2.74 | 9.92 | 0.246 |
Yes | 0.6 | 0.23 | 0.89 | 8.06 | 5.5 | 10.3 | ||
CHD | ||||||||
No | 0.68 | 0.26 | 0.96 | 0.691 | 7.93 | 4.82 | 10.03 | 0.268 |
Yes | 0.85 | 0.35 | 1.1 | 8.84 | 8.04 | 14.24 | ||
CKD | ||||||||
CKD on HD | 0.65 | 0.26 | 0.8 | 0.663 | 2.63 | 1.82 | 9.19 | 0.268 |
No | 0.71 | 0.3 | 0.99 | 8.05 | 5.06 | 10.15 | ||
Ventilation | ||||||||
1 (PEEP) | 0.6 | 0.13 | 0.97 | 0.197 | 8.84 | 6.03 | 10.15 | 0.010* 1 vs 3 3 vs 4 |
2 (mask) | 0.82 | 0.37 | 0.94 | 5.71 | 5.06 | 9.92 | ||
3 (CPAP) | 1.45 | 0.83 | 1.56 | 1.71 | 1.38 | 2.33 | ||
4 (mechanical) | 0.45 | 0.35 | 0.9 | 8.84 | 5.78 | 10.42 | ||
GGO | ||||||||
Yes | 0.71 | 0.31 | 0.96 | 0.691 | 7.93 | 4.82 | 10.03 | 0.251 |
No | 0.6 | 0.1 | 1 | 9.92 | 8.06 | 10.3 | ||
Peripheral patches | ||||||||
Yes | 0.89 | 0.6 | 1 | 0.701 | 8.95 | 8.06 | 9.92 | 0.284 |
No | 0.68 | 0.26 | 0.94 | 7.93 | 4.58 | 10.15 | ||
Ivermectin | ||||||||
No | 0.68 | 0.35 | 0.97 | 0.468 | 7.93 | 4.58 | 10.15 | 0.206 |
Yes | 0.7 | 0.15 | 0.8 | 8.9 | 8.84 | 9.92 | ||
Remedesevir | ||||||||
No | 0.8 | 0.32 | 1 | 0.222 | 7.06 | 4.23 | 10.03 | 0.368 |
Yes | 0.58 | 0.15 | 0.85 | 8.84 | 5.5 | 10.15 | ||
Favipiravir | ||||||||
No | 0.71 | 0.35 | 0.97 | 0.078 | 7.99 | 5.06 | 9.92 | 0.118 |
Yes | 0.09 | 0.09 | 0.09 | 12.23 | 12.23 | 12.23 | ||
Ribavirin | ||||||||
No | 0.71 | 0.35 | 0.97 | 0.196 | 8.05 | 5.06 | 10.15 | 0.667 |
Yes | 0.13 | 0.13 | 0.13 | 5.5 | 5.5 | 5.5 | ||
First PCR | ||||||||
Negative | 0.38 | 0.23 | 1 | 0.443 | 8.84 | 6.2 | 9.92 | 0.400 |
Positive | 0.71 | 0.37 | 0.94 | 7.93 | 3.88 | 10.15 | ||
RSNA | ||||||||
Atypical | 0.24 | 0.24 | 0.24 | 0.506 | 5.71 | 5.71 | 5.71 | 0.621 |
Undetermined | 0.26 | 0.23 | 1 | 5.58 | 2.63 | 9.92 | ||
Typical | 0.71 | 0.37 | 0.9 | 8.59 | 5.06 | 10.15 | ||
CXR18 (0–18) | ||||||||
Mild | 0.76 | 0.4 | 0.95 | 0.342 | 5.52 | 3.31 | 8.2 | 0.009* Mild vs Severe |
Moderate | 0.7 | 0.35 | 1.07 | 8.84 | 5.26 | 10.15 | ||
Severe | 0.45 | 0.23 | 0.8 | 10.56 | 9.19 | 10.69 | ||
TSS total score (0–20) | ||||||||
None | 0.24 | 0.24 | 0.24 | 0.462 | 5.71 | 5.71 | 5.71 | 0.540 |
Mild | 0.80 | 0.37 | 1.00 | 6.20 | 4.58 | 9.92 | ||
Moderate | 0.65 | 0.35 | 0.94 | 8.84 | 5.06 | 10.15 |